https://ucb.com

Home | UCBHome | UCB Skip to main content UCB's Global Corporate Website Healthcare Professionals Patients Investor Relations Careers instagram facebook twitter youtube linkedin rss Home UCB - Inspired by patients. Driven by science. Previous Slide◀︎ Next Slide▶︎ Current Slide Scroll down to discover UCB Main navigation UCB - Inspired by patients. Driven by science. Chercher Our Company About Us Management Sustainability Health of the Planet Conserving water Health of the planet - CO2e Reducing waste Partnering Suppliers Become our supplier Our Team Requisition to Pay Process Funding Funding Grants Investigator-Initiated Studies Disclosure Of Payments Disclosure of payments to Healthcare Professionals Belgium Denmark Finland Hungary Ireland Italy Netherlands Norway Other countries Romania Sweden Ukraine Responsible Procurement Digital Business Transformation Ethical Business Practices Our positions Disease Areas Disease areas Epilepsy New Our Science Overview Drug discovery Capabilities R&D locations Clinical studies Innovation is Pipeline Clinical Studies Overview Clinical studies at UCB: How are medicines made and tested? Current studies Clinical studies index Rozanolixizumab (Rystiggo®) Zilucoplan (Zilbrysq®) General information Data Transparency Policy Access to Patient-Level Clinical Study Data Plain Language Summaries of research results Peer-Reviewed Publications Registration and Results Reporting on Public Registries Study Reports and Synopses Our Products Products Bimzelx® Briviact® Cimzia® - Ankylosing spondylitis (AS) Cimzia® - Axial spondyloarthritis (axSpA) Cimzia® - Crohn's disease Cimzia® - Plaque psoriasis (PsO) Cimzia® - Psoriatic arthritis (PsA) Cimzia® - Rheumatoid arthritis (RA) Evenity® Fintepla® Keppra® Nayzilam Neupro® - Parkinson's disease Neupro® - Restless Legs Syndrome RYSTIGGO Vimpat® Newsroom Overview Press releases Form Our stories Resources Contact HCP HCP Overview Women of childbearing age Immune to the impossible Podcasts Patients Overview Life stories Women of Childbearing Age Investors Overview UCB equity story UCB financials Full year financial results Half-year financial results UCB Governance UCB shareholders Share repurchase program Shareholders meeting 2016 Shareholders meeting 2018 Shareholders meeting 2019 Shareholders meeting 2020 ESG overview Download center EMTN Notes documents Eurobond 2013 documents Eurobond 2021 - documents Exchange offer documents IR team Careers Applying to UCB Go to global site  Search Country Navigator Browser Update Dear User, Some of the functionalities available on UCB's internet website www.ucb.com might not work properly with Internet Explorer. For a better user experience, we advise you to access the website with one of the following browsers: Microsoft Edge Mozilla Firefox Google Chrome close Listen   At UCB, we believe that everyone deserves to live the best life that they can. That’s why – as a global biopharmaceutical leader - we’re focused on creating valuable solutions that make improvements to the lives of people living with neurological and autoimmune conditions now and into the future. We work closely and forge strong connections with patients, caregivers, health care professionals and other stakeholders who know the challenges of these diseases and where the unmet needs are found all too well. UCB’s foundational commitment to crafting valuable solutions and delivering medicines that aim to improve lives is at the core of all that we do, as we live our purpose each day, bringing together the expertise, talent, tools, and scientific ingenuity needed to pursue what’s right for those who live with severe diseases.  Learn more as a patient Learn more as a healthcare professional Find out more about UCBCares Discover our Clinical Studies section UCB Stories & Newsroom Story 26 Sep 2024 ASBMR Annual Meeting 2024 overview: prioritizing patient-centered careRead more Story 25 Sep 2024 UCB at EADV 2024: committed to advancing care in immuno-dermatology Read more Press release 30 Sep 2024 UCB announces a head-to-head study evaluating BIMZELX[®]▼(bimekizumab) versus SKYRIZI® (risankizumab) in active psoriatic arthritis Read More View all Driven to create breakthrough medicinesthat will make a real difference to people's livesNeil, UCB UCB on Twitter Tweets by ucb_news UCB on Facebook Posts from @UCBglobal Posts from UCBglobal   Instagram Feed ucbglobal Sep 30, 2024 ucbglobal Sep 28, 2024 Read more about our sustainability approach learn more about UCB Ventures Choose a Country Global Site – English Australia – English België – Engels Belgique – Anglais Brasil – Português България – Български Canada – English Canada – Français 中国 – 中文 Česká Republika – Angličtina Danmark – Engelsk Deutschland – Deutsch France – Français España – Español Ελλάδα – Ελληνικά India – English Ireland – English Italia – Inglese 日本 – 日本語 한국 – 한국어 Luxembourg – Anglais Luxemburg – Engels Magyarország – Angol México & Latinoamérica – Español Nederland – Engels New Zealand – English Norge – Engelsk Österreich – Deutsch Polska – Polski Portugal – español y portugués România – Engleză Россия – Русский Slovensko – Anglický Suomi – Englanti Sverige – Engelska Schweiz – Deutsch Türkiye – Türkçe Україна – Англійська United Kingdom – English U.S.A. – English × Our Company About us Management Sustainability Health of the Planet Partnering Suppliers Funding Disclosure of payments Digital Business Transformation Ethical Business Practices Our positions Disease Areas Disease Areas Our Science Drug discovery Capabilities R&D locations Clinical Studies Innovation is Pipeline UCB Worldwide Select country Search Our Products Products Newsroom Overview Press Releases Our stories Resources Contact Patients Patients Life stories Women of Childbearing Age Investors Overview UCB equity story UCB financials UCB Governance UCB shareholders ESG overview Download center IR team HCP HCP Overview Women of childbearing age Immune to the impossible Clinical Studies Overview Current studies Clinical studies index General information Data Transparency Policy FOLLOW US ON Instagram Facebook Twitter YouTube LinkedIn RSS Careers Contact us © 2007 -2024 UCB S.A., Belgium. All rights reserved. instagram facebook twitter youtube linkedin rss Country Navigator Global Site – English Australia – English België – Engels Belgique – Anglais Brasil – Português България – Български Canada – English Canada – Français 中国 – 中文 Česká Republika – Angličtina Danmark – Engelsk Deutschland – Deutsch France – Français España – Español Ελλάδα – Ελληνικά India – English Ireland – English Italia – Inglese 日本 – 日本語 Казахстан – ағылшын тілі 한국 – 한국어 Luxembourg – Anglais Luxemburg – Engels Magyarország – Angol México & Latinoamérica – Español Nederland – Engels New Zeeland – English Norge – Engelsk Österreich – Deutsch Polska – Polski Portugal – Inglês România – Engleză Россия – Русский Slovensko – Anglický Suomi – Englanti Sverige – Engelska Schweiz – Deutsch Suisse – Français Türkiye – Türkçe Україна – Англійська United Kingdom – English U.S.A. – English Footer menu Legal Notice Website Privacy Policy Cookie policy Cookie Preferences Privacy Policy for Suppliers Privacy Policy for Shareholders Privacy Policy for Healthcare Professionals Pharmacovigilance privacy policy Contact Us / UCB CARES UCB Worldwide Sitemap General Patient Privacy Policy © 2007 - 2024 UCB S.A., Belgium. All rights reserved. Last updated on: September, 03, 2024enen1732416781https://ucb.com

Modificare il tuo sito?

Cosa fai?